Fidelity Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-864,288	Closed	-$14.7M	–	4770
2020 Q4	$14.7M	Buy	864,288 +863,888	+215,972%	+$10.8M	﹤0.01%	1835
2020 Q3	$2K	Buy	+400	New	+$2.03K	﹤0.01%	3515
2020 Q2	–	Sell	-1,250	Closed	-$3K	–	4394
2020 Q1	$3K	Buy	1,250 +750	+150%	+$3.18K	﹤0.01%	3373
2019 Q4	$2K	Sell	500 -301,512	-100%	-$1.19M	﹤0.01%	3612
2019 Q3	$1.17M	Sell	302,012 -1,506,672	-83%	-$8.27M	﹤0.01%	2397
2019 Q2	$10.9M	Sell	1,808,684 -1,890,384	-51%	-$18.1M	﹤0.01%	1850
2019 Q1	$49.6M	Sell	3,699,068 -8,700	-0.2%	-$99.2K	0.01%	1216
2018 Q4	$34.5M	Sell	3,707,768 -328,545	-8%	-$3.91M	﹤0.01%	1322
2018 Q3	$56.2M	Sell	4,036,313 -1,245,050	-24%	-$18.5M	0.01%	1215
2018 Q2	$83.5M	Buy	5,281,363 +52,319	+1%	+$913K	0.01%	1034
2018 Q1	$89.8M	Buy	5,229,044 +889,538	+20%	+$17.4M	0.01%	1032
2017 Q4	$95.1M	Buy	4,339,506 +4,240	+0.1%	+$136K	0.01%	1017
2017 Q3	$177M	Buy	4,335,266 +17,447	+0.4%	+$548K	0.02%	728
2017 Q2	$130M	Sell	4,317,819 -25,682	-0.6%	-$802K	0.02%	856
2017 Q1	$157M	Buy	4,343,501 +77,381	+2%	+$3.41M	0.02%	799
2016 Q4	$214M	Buy	4,266,120 +14,642	+0.3%	+$769K	0.03%	637
2016 Q3	$223M	Buy	4,251,478 +1,434,270	+51%	+$68.5M	0.03%	619
2016 Q2	$116M	Buy	2,817,208 +547,808	+24%	+$23.8M	0.02%	907
2016 Q1	$92.2M	Buy	+2,269,400	New	+$78M	0.01%	999